EUROPEAN PROJECTS
PRECISEU launches its Expression of Interest to promote personalised healthcare across Europe
The European project PRECISEU, of which Clust-ER Health is a partner, has launched its Expression of Interest (EoI), open from 20 May to 31 July 2025, inviting innovators, researchers, companies, and institutions to join the project’s mission to advance personalised medicine through cross-regional collaboration and innovation support.
About the PRECISEU project
The general purpose of PRECISEU is connecting innovation ecosystems across Europe to efficiently advance towards a truly personalised healthcare, transferring practices and solutions from region to region and scaling up deep-tech healthcare innovations based on advanced therapies medicinal products and health data across Europe.
More precisely, PRECISEU aims to:
- 🚀Accelerate the adoption of personalised medicine
- 🤝Foster cross-European collaboration
- 🔄Facilitate the exchange of knowledge and solutions
- 🧬Support the scale-up of cutting-edge health technologies of personalised medicine
Innovation Support Programme
To achieve the connection between ecosystems , PRECISEU is launching a non-binding Expression of Interest (EoI) process.
PRECISEU is implementing an Innovation Support Programme with funnelling and monitoring phases, supporting concrete interregional projects to be implemented by consortia with research and innovation entities from participating regions; to bring innovations on the use of health data for R&I; to make ATMPs sustainable and affordable, and to introduce PM in regional healthcare systems, even in regions with lower innovation performance.
What is the EoI call about?
The EoI is a non-binding call designed to map the landscape of stakeholders and ideas relevant to PRECISEU’s objectives. It allows organisations and individuals to express their interest in:
- Presenting initial ideas or advanced concepts in personalised medicine
- Offering technological expertise or services
- Seeking collaboration opportunities
- Joining or forming consortia
- Taking part in future mentoring and matchmaking activities
Submitting an EoI does not constitute a formal application for funding, but it is a recommended first step to benefit from the full range of support services offered by the PRECISEU consortium.
Key dates
🗓️ 20 May – 31 July 2025: EoI Submission Period
🧭 June – October 2025: Funnelling, Mentoring, and Matchmaking Activities
🚀 November – December 2025: PRECISEU Open Call for full proposals
Who can apply?
- SMEs and startups
- Research institutions and universities
- Hospitals and healthcare providers
- NGOs and patient organisations
- Large companies
- Public and private entities
Eligible regions
Organisations from the following regions are encouraged to participate: Catalonia, Baden-Württemberg, Emilia-Romagna, Flanders, Gothenburg, Region of Crete, Lithuania, Nord East Romania, Rivne, Madrid, The Netherlands and Sofia.
What support does PRECISEU offer?
Selected EoIs will gain access to a tailored Innovation Support Programme that includes:
- Mentoring and Funnelling: Expert mentoring to refine ideas, identify funding opportunities, and build strong, balanced consortia across regions.
- Matchmaking Events: Brokerage and networking activities connecting relevant stakeholders to form competitive cross-regional consortia.
- Proposal Preparation Support: Hands-on guidance on developing business models, understanding market and regulatory challenges, IPR, team building, and impact assessment (e.g. gender, diversity, economic).
Ready to join?
Submit your Expression of Interest via the official online form (in English).
Need more information?
Download the detailed Expression of Interest (EoI) document to find all the guidelines, requirements, and full explanation of the process.
📄PRECISEU Expression of Interest
Do you have questions?
Contact the representative of your region—contact details are available at the end of the document.
🚀 Let’s build the future of personalised healthcare together!
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.
